Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
MORC (microrchidia) is a highly conserved nuclear protein superfamily with MORC family members in humans, mice, nematodes, plants (such as Arabidopsis) and myxobacteria. MORC2 (also known as ZCWCC1, ZCW3, KIAA0852 or AC004542.C22.1) is a ubiquitously expressed protein involved in chromatin remodeling, promoting DNA double strand break (DSB) repair and cell survival. In response to DNA damage, MORC2 is phosphorylated by p21-activated kinase 1 (PAK1) and regulates chromatin remodeling through its DNA-dependent ATPase activity. The cytoplasmic MORC2 also exerts a role unrelated to transcriptional regulation: when preadipocytes differentiate into adipocytes, MORC2 expression is up-regulated and interacts with ATP-citrate lyase (ACLY), which promotes ATP-ACLY Activated to promote adipogenesis and adipogenic differentiation.
MORC2 also forms a protein complex with histone deacetylase 4 (HDAC4), which exerts a negative transcriptional regulation through epigenetic means. The first downstream gene, CAIX, which is directly regulated by MORC2, has been identified. A small amount of MORC2 expressed in the cytoplasm also exerts an effect unrelated to the function of regulating transcription: when the preadipocytes differentiate into adipocytes, the MORC2 content in the cytoplasm rises and interacts with ATP-citrate lyase, Promoting the activation of the latter. Studies have shown that after overexpression of MORC2, p53 protein levels in L02 hepatocytes decreased before and after induction of steatosis. qRT-PCR and Westernblot confirmed p53 overexpression was successful, and overexpression of p53 partially relieved MORC2 from alleviating L02 hepatic steatosis effect.
Figure 1. MORC2 and ACLY interact in the cytosol of MCF-7 cells. (Sánchez-Solana, et al. 2014)
MORC2 and Tumor
The C-terminus of MORC2 contains a nuclear localization signal and a proline-rich domain that is critical for the transcriptional repression of MORC2 in tumor cells. The study used gene expression profiling to analyze the gene expression profile of cancer tissues in patients with triple-negative breast cancer and found that MORC2 can predict the risk of recurrence of triple-negative breast cancer. In 2014, Tuupanen et al. reported that MORC2 is one of the candidate oncogenes for mutations in microsatellite unstable colorectal cancer. MORC2 is capable of exerting negative transcriptional regulation through epigenetic means. In gastric cancer cells, MORC2 is able to recruit the histone deacetylase HDAC4 and down-regulate the acetylation level of histone H3 at the carbonic anhydrase IX (CA IX) promoter, thereby down-regulating the expression of CA IX.
In addition, MORC2 is also able to recruit enmethylcer of zeste homolog 2 to promote the trimethylation of H3K27, thereby down-regulating the transcription of the Arg-binding protein 2 gene. It was found that both MORC2 and HSF1 (heat shock factor 1) promoted the binding of PRC2 (polycomb repressive complex 2) and EZH2 to the ArgBP2 enhancer and promoter, enhancing the trimethylation of H3K27, resulting in tight chromatin structure and thus inhibition. ArgBP2 transcription. ArgBP2 is lowly expressed in gastric cancer and can inhibit the proliferation, migration and invasion of gastric cancer cells. Therefore, it is speculated that MORC2 may promote the proliferation, migration and invasion of gastric cancer cells by down-regulating ArgBP2, thereby promoting the occurrence and development of gastric cancer. Moreover, the methionine→isoleucine mutation (M276I) at position 276 of the MORC2 residue regulates the splicing of the cell surface adhesion molecule CD44 protein by heterogeneous nuclear ribonucleoprotein M (hnRNPM), which promotes Migration, infiltration and lung metastasis of triple negative breast cancer.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.